Docetaxel,Carboplatin,Trastuzumab and Bevacizumab for Breast Cancer and Bone Marrow Micrometastases

NCT00949247 · clinicaltrials.gov ↗

EARLY_PHASE1

Phase

COMPLETED

Status

20

Enrollment

OTHER

Sponsor class

Conditions

Breast Cancer

Interventions

BIOLOGICAL: bevacizumab
BIOLOGICAL: trastuzumab
DRUG: carboplatin
DRUG: docetaxel
OTHER: laboratory biomarker analysis

Sponsor

Case Comprehensive Cancer Center